Mirae Asset Global Etfs Holdings Ltd. Tyra Biosciences, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 11,641 shares of TYRA stock, worth $129,215. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,641
Previous 11,109
4.79%
Holding current value
$129,215
Previous $261,000
38.31%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TYRA
# of Institutions
112Shares Held
43.1MCall Options Held
3.8KPut Options Held
6K-
Ra Capital Management, L.P. Boston, MA10.6MShares$118 Million2.39% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.18MShares$46.4 Million97.27% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$45.3 Million89.47% of portfolio
-
Nextech Invest Ag4.06MShares$45 Million10.51% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$43.8 Million2.05% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $466M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...